Literature DB >> 2903590

Treatment of acute toxaemic fascioliasis.

Z Farid1, M Kamal, J Woody.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2903590     DOI： 10.1016/0035-9203(88)90452-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  5 in total

Review 1.  Anthelminthic agents: some recent developments and their clinical application.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

2.  Praziquantel failure in the treatment of Fasciola hepatica.

Authors:  D M Patrick; J Isaac-Renton
Journal:  Can J Infect Dis       Date:  1992-01

3.  Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects.

Authors:  Walid H El-Tantawy; Heba F Salem; Nirmeen A S Mohammed Safwat
Journal:  Pharm World Sci       Date:  2007-01-30

Review 4.  Early Postnatal and Preschool-Age Infection by Fasciola spp.: Report of Five Cases from Vietnam and Worldwide Review.

Authors:  Nguyen Van De; Thanh Hoa Le; Veronica H Agramunt; Santiago Mas-Coma
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

5.  Triclabendazole in the treatment of human fascioliasis: a review.

Authors:  Preetam Gandhi; Esther K Schmitt; Chien-Wei Chen; Sanjay Samantray; Vinay Kumar Venishetty; David Hughes
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-12-01       Impact factor: 2.184
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.